RMD · ResMed Inc.
$218.27
-0.60% last session
End-of-day data · close of 2026-09-11
Market cap
$32B
Enterprise value
$31B
Trailing P/E
21.1
Forward P/E
16.6
Dividend yield
1.0%
Beta
0.77
Avg volume
1M
Employees
11K
Daily Change %
-0.60%
5 Days Change
-3.68%
10 Days Change
-8.39%
30 Days Change
-1.89%
60 Days Change
8.20%
Month to Day Change
-4.93%
Year to Day Change
-7.94%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — RMD
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-08-31
Latest call per bank · past 12 months
RBC Capital
Sector Perform$244
+11.1% vs priceWells Fargo
Equal-Weight$215
-2.1% vs priceCitigroup
Neutral$235
+7.0% vs priceJefferies
Hold$225
+2.5% vs priceMorgan Stanley
Equal-Weight$230
+4.7% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-31 | Keybanc | Maintains | Overweight | $255 → $267 |
| 2026-08-19 | Rothschild & Co | Initiates | Neutral | $0.00 → $230 |
| 2026-08-07 | RBC Capital | Maintains | Sector Perform | $234 → $244 |
| 2026-08-07 | Piper Sandler | Maintains | Neutral | $233 → $225 |
| 2026-08-07 | Keybanc | Maintains | Overweight | $260 → $255 |
| 2026-08-07 | Wells Fargo | Maintains | Equal-Weight | $225 → $215 |
| 2026-07-15 | Mizuho | Maintains | Outperform | $235 → $220 |
| 2026-07-13 | Citigroup | Downgrade | Buy → Neutral | $270 → $235 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-09-11
- RSI (14): RSI is 42 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 0.8% above the 50-day MA ($216.55).
- Price vs 200-day MA: Trading 3.7% below the 200-day MA ($226.68).
- MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
- MACD (12,26,9): MACD histogram is negative (-2.79) — short-term momentum is fading.
- 52-week range: Price sits between the 52-week low ($182.30) and high ($280.31).
RMD Price Chart
Loading chart for RMD…
Fundamentals
About ResMed Inc.
ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software. The company offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. It also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
More in Medical Instruments & Supplies
ISRG
Intuitive Surgical, Inc.
$129B -37.6% YTD
BDX
Becton, Dickinson and Company
$48B 20.1% YTD
MDLN
Medline Inc.
$44B -18.9% YTD
ALC
Alcon Inc.
$32B -12.8% YTD
WST
West Pharmaceutical Services, I
$24B 22.8% YTD
SOLV
Solventum Corporation
$15B 13.6% YTD
BAX
Baxter International Inc.
$13B 27.8% YTD
COO
The Cooper Companies, Inc.
$11B -22.6% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.